Published in Am J Physiol Cell Physiol on September 18, 2002
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms. Theranostics (2014) 0.95
PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors. J Biol Chem (2012) 0.81
Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells. J Exp Clin Cancer Res (2009) 0.81
Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells. Br J Pharmacol (2004) 0.80
Somatostatin Improved B Cells Mature in Macaques during Intestinal Ischemia-Reperfusion. PLoS One (2015) 0.75
Effects of AP‑1 and NF‑κB inhibitors on colonic endocrine cells in rats with TNBS‑induced colitis. Mol Med Rep (2016) 0.75
Gastrointestinal neuroendocrine peptides/amines in inflammatory bowel disease. World J Gastroenterol (2017) 0.75
Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. Circulation (2006) 3.99
Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet (2004) 2.17
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet (2011) 1.98
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood (2006) 1.89
Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics (2003) 1.61
Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. Eur Heart J (2008) 1.52
Gender-dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty. J Orthop Res (2008) 1.44
Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med (2013) 1.28
PCR-amplification of GC-rich regions: 'slowdown PCR'. Nat Protoc (2008) 1.25
Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med (2013) 1.23
Restless legs syndrome and risk of incident cardiovascular disease in women and men: prospective cohort study. BMJ Open (2012) 1.16
Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity. Eur J Pharmacol (2005) 1.16
Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique. Pharmacogenetics (2003) 1.14
Comparison of manual and automated nucleic acid extraction from whole-blood samples. J Clin Lab Anal (2007) 1.10
Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion. JACC Cardiovasc Interv (2013) 1.06
The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.03
The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Clin Cancer Res (2007) 1.02
The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.00
Migraine and functional outcome from ischemic cerebral events in women. Circulation (2010) 0.99
Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med (2007) 0.99
The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis. Anesthesiology (2013) 0.99
Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur J Hum Genet (2005) 0.99
The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clin Cancer Res (2006) 0.98
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. Blood (2010) 0.96
GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin Cancer Res (2005) 0.96
Regulatory BCL2 promoter polymorphism (-938C>A) is associated with adverse outcome in patients with prostate carcinoma. Int J Cancer (2011) 0.95
Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics (2002) 0.95
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res (2006) 0.94
Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol (2005) 0.93
The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression. Pharmacogenet Genomics (2011) 0.92
Prognostic assessment of three single-nucleotide polymorphisms (GNB3 825C>T, BCL2-938C>A, MCL1-386C>G) in extrahepatic cholangiocarcinoma. Cancer Invest (2010) 0.91
The T393C polymorphism in the gene GNAS1 of G protein is associated with survival of patients with invasive breast carcinoma. Breast Cancer Res Treat (2006) 0.91
Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene. Clin Cancer Res (2008) 0.91
A novel functional haplotype in the human GNAS gene alters Galphas expression, responsiveness to beta-adrenoceptor stimulation, and peri-operative cardiac performance. Eur Heart J (2009) 0.90
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas. Breast Cancer Res Treat (2009) 0.89
Decreased expression of miR-133a but not of miR-1 is associated with signs of heart failure in patients undergoing coronary bypass surgery. Cardiology (2013) 0.89
Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med (2003) 0.89
A genome-wide analysis of 'Bounty' descendants implicates several novel variants in migraine susceptibility. Neurogenetics (2012) 0.88
No association of the NFKB1 insertion/deletion promoter polymorphism with survival in colorectal and renal cell carcinoma as well as disease progression in B-cell chronic lymphocytic leukemia. Pharmacogenet Genomics (2006) 0.88
Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins. Cell Signal (2003) 0.88
Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J (2003) 0.88
Correlation of aquaporin-1 water channel protein expression with tumor angiogenesis in human astrocytoma. Anticancer Res (2013) 0.87
G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension (2003) 0.87
GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma. Neoplasia (2007) 0.87
Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics (2002) 0.87
Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancer. Int J Biol Markers (2010) 0.87
Migraine and restless legs syndrome in men. Cephalalgia (2012) 0.87
A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men. Basic Res Cardiol (2008) 0.86
Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome. Crit Care Med (2008) 0.86
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia. Leuk Lymphoma (2009) 0.85
Epigenetics in primary headaches: a new avenue for research. J Headache Pain (2008) 0.85
Nutrigenomics: where are we with genetic and epigenetic markers for disposition and susceptibility? Nutr Rev (2010) 0.85
Role of G protein beta3 subunit C825T and HLA class II polymorphisms in the immune response after HBV vaccination. Virology (2002) 0.85
A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. Pharmacogenet Genomics (2008) 0.85
Quantification of G protein Gaalphas subunit splice variants in different human tissues and cells using pyrosequencing. Gene Expr (2005) 0.84
Newest aspects on the association between migraine and cardiovascular disease: the role of modifying factors. Curr Pain Headache Rep (2009) 0.84
The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx. Laryngoscope (2008) 0.84
Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women. Stroke (2013) 0.84
Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme. J Neurosurg (2011) 0.84
Molecular basis of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 0.84
A 3'UTR polymorphism modulates mRNA stability of the oncogene and drug target Polo-like Kinase 1. Mol Cancer (2014) 0.82
Cooperative effect of GNB3 825C>T and GPIIIa PI(A) polymorphisms in enhanced platelet aggregation. Thromb Res (2003) 0.82
The prevalence of the c-kit exon 10 variant, M541L, in aggressive fibromatosis does not differ from the general population. J Clin Pathol (2011) 0.82
A novel aspect of GNAS imprinting: higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol Cell Endocrinol (2011) 0.82
Restless legs syndrome and all-cause mortality in four prospective cohort studies. BMJ Open (2012) 0.81
An X chromosome association scan of the Norfolk Island genetic isolate provides evidence for a novel migraine susceptibility locus at Xq12. PLoS One (2012) 0.81
Prognostic relevance of the AQP5 -1364C>A polymorphism in primary breast cancer. Mol Med Rep (2011) 0.81
The human G protein beta4 subunit: gene structure, expression, Ggamma and effector interaction. FEBS Lett (2003) 0.81
Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Clin Pharmacol Ther (2004) 0.81
Aquaporin 5 gene promoter--1364A/C polymorphism associated with 30-day survival in severe sepsis. Anesthesiology (2011) 0.81
Licensing the future: report on BioMed Central's public consultation on open data in peer-reviewed journals. BMC Res Notes (2013) 0.80
Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer. World J Gastroenterol (2009) 0.80
Characterization of the splice variant Gbeta3v of the human G-protein Gbeta3 subunit. Biochim Biophys Acta (2003) 0.80
Migraine, headache, and the risk of depression: Prospective cohort study. Cephalalgia (2013) 0.80
Expression of aquaporin 5 and the AQP5 polymorphism A(-1364)C in association with peritumoral brain edema in meningioma patients. J Neurooncol (2013) 0.80
Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. World J Urol (2005) 0.80
Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina--the role of GNB3 C825T polymorphism. Am Heart J (2006) 0.80
1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. Eur J Haematol (2004) 0.80
SNPs in genes encoding G proteins in pharmacogenetics. Pharmacogenomics (2011) 0.80
G protein beta3 subunit 825T allele is associated with depression in young, healthy subjects. Neuroreport (2003) 0.80
The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism. Clin Pharmacol Ther (2006) 0.80
The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol (2006) 0.80
The G-Allele of the PSMA6-8C>G polymorphism is associated with poor outcome in multiple myeloma independently of circulating proteasome serum levels. Eur J Haematol (2010) 0.79